Australia Tas clot case likely linked to AstraZeneca

07:30  06 may  2021
07:30  06 may  2021 Source:   aap.com.au

EU sues AstraZeneca over vaccine delivery

  EU sues AstraZeneca over vaccine delivery The European Commission has launched legal action against COVID-19 vaccine manufacturer AstraZeneca, after weeks of public criticism. News of plans to take legal action for an alleged breach of contractual obligations emerged last week but was not confirmed until Monday, in a tweet by an official.European Commissioner for Health and Food Safety Stella Kyriakides said the commission's priority was to ensure vaccine deliveries take place to protect the health of the European Union.READ MORE: Pfizer and Moderna could be produced in Australia © AP The AstraZeneca vaccine.

A Tasmanian man is in hospital after developing blood clots a week after getting the AstraZeneca coronavirus vaccine.

A 70 year old Tasmanian man has developed blood clots a week after getting the AstraZeneca vaccine. © EPA PHOTO A 70 year old Tasmanian man has developed blood clots a week after getting the AstraZeneca vaccine.

The 70-year-old reported symptoms seven days after getting the jab.

Australia's medical regulator has found the 70-year-old's case was likely linked to the vaccine..

Tasmania's Department of Health has put together an expert advisory panel to review the case.

Acting director of public health Scott McKeown is urging Tasmanians to keep getting the vaccine.

"I want to reassure Tasmanians that vaccination remains the best way to protect against severe illness and death from COVID-19 and is a core element of the pandemic response," Dr McKeown said.

US to share up to 60 million doses of AstraZeneca COVID vaccine

  US to share up to 60 million doses of AstraZeneca COVID vaccine AstraZeneca is not yet approved for distribution in the United States – US officials are going to share what they have.The move on Monday greatly expands on the Biden administration’s action last month to loan about four million doses of the vaccine to Mexico and Canada. The AstraZeneca vaccine is widely in use around the world but has not yet been authorised by the US Food and Drug Administration (FDA).

Video: No evidence linking two deaths to AstraZeneca jab (ABC NEWS)

Thrombosis with thrombocytopaenia syndrome is rare but can be deadly.

Australian immunisation experts say it occurs in about six per million people vaccinated.

In its latest data release, the Therapeutic Goods Administration has said there have been 11 cases of the syndrome as of May 2.

There had been 1.4 million AstraZeneca doses administered at that point.

Of the 11 cases, five were revealed by the TGA on Thursday.

They include the 70-year-old Tasmanian man, a 74-year-old man and a 51-year-old woman from Victoria, a 66-year-old man from Queensland and a 64-year-old woman from Western Australia.

India coronavirus death toll passes 250,000, variant spreads .
India's coronavirus death toll passed 250,000 on Wednesday as the World Health Organization said the variant fuelling the surge had been found in dozens of countries across the globe. While vaccinations have helped to ease the pandemic crisis in the United States and Europe, India is in the grip of a devastating wave. Another 4,205 deaths were on Wednesday confirmed over the previous 24 hours, a national record, taking total fatalities to 254,197.But many experts believe the official numbers of people dying in India, which has one of the world's most poorly funded health care systems, are an underestimate.

usr: 0
This is interesting!